Location of Repository

Sphingosomes a novel approach to vesicular drug delivery

By Int J Cur Sci Res. Shailendra Saraf Chanchal Deep Kaur Deepankar Gupta Swarnlata Saraf.

Abstract

Vesicular systems have been realized as extremely useful carrier systems in various scientific domains. Sphingosomes is bilayered vesicles in which an aqueous volume is entirely enclosed by membrane lipid bilayer mainly composed of natural or synthetic sphingolipid. Sphingosomes solve the major drawback of vesicle system (liposomes, niosomes) like less stability, less in vivo circulation time, low tumor loading efficacy in case of cancer therapy. Sphingosomes are clinically used delivery system for chemotherapeutic agent, biological macromolecule and diagnostics. Due to flexibility in size and composition, different types of sphingosomes have been developed. The out come of this review is that sphingosomes represents a promising vesicular drug delivery system to delivers therapeutic compounds for a range of possible applications

Topics: JOURNALS
Publisher: CurrentSciDirect Publications
Year: 2011
OAI identifier: oai:cogprints.org:7311
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://cogprints.org/7311/1/Sp... (external link)
  • http://cogprints.org/7311/ (external link)
  • Suggested articles

    Preview

    Citations

    1. Biological approaches to the controlled delivery of drugs: a critical review.
    2. (1990). Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradient. doi
    3. (1987). Controlled Drug Delivery: Fundamentals and Applications, 2nd Edn., Vol 29,
    4. Diffusion of. univalent ions across the lamellae of swollen phospholipid.
    5. (2006). et al Thrombus Localization by Using Streptokinase Containing Vesicular Systems. Drug Delivery doi
    6. (1995). Immunoliposome mediated targeting of anti cancer drugs in vivo.
    7. In vivo behavior of vesicular urokinase.
    8. (2006). Inex Pharmaceutical Corporation. Liposomal camptothecins and uses there of. US Patent 7060828.
    9. (1998). Inex Pharmaceutical Corporation. Sphingosome for enhanced drug delivery.US Patent 5741516.
    10. Liposomes in thrombolytic therapy t-PA targeting with plasminogen-liposomes, a novel concept. The Netherlands Utrecht University:1995.
    11. Liposomes Technology. Vol 3.
    12. Medical Applications Of Liposomes
    13. Targeted Drugs. 2nd Edn.
    14. (1977). Targeting of drugs.
    15. (1990). The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey. doi
    16. (2005). Vectron therapeutic AG. Drug delivery vehicles and uses theirof. European Patent 1537858.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.